We have evidence to show that inhibition of K-RAS downstream effector MEK signaling by AZD6244, but not the PI3K signaling by BEZ235, reduced Hh target gene GLI1 expression in pancreatic cancer cells (Figure S2). This evidence concerns the gene KRAS and pancreatic neoplasm.